Segmentectomy results in better preservation of pulmonary function compared with lobectomy in patients with early-stage NSCLC, according to a study published in The Journal of International ...
Atezolizumab after adjuvant chemotherapy offers a promising treatment option for patients with resected early-stage NSCLC, according to a study published in The Lancet. Researchers who evalu...
Pretreatment fibrotic interstitial lung abnormalities (ILAs) were associated with postoperative pulmonary complications (PPC)s, higher postoperative mortality, and longer hospital stay in a ...
Efficacy pronounced for patients with PD-L1 expression on 50% or more tumor cells Use of the programmed death-ligand-1 (PD-L1) inhibitor atezolizumab (Tecentriq) after adjuvant chemothera...
This study states that Historically, the prognosis for patients with metastatic non–small-cell lung cancer (NSCLC) has been poor, with 5-year survival of approximately 6%.1 However, the in...
There is an increasing number of driver fusions in NSCLC which are amenable to targeted therapy. Panel testing for fusions is increasingly appropriate but can be costly and requires adequate...
To investigate the inter- and intra-reader agreement of immune Response Evaluation Criteria in Solid Tumors (iRECIST) and Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1...
Long non-coding RNAs (lncRNAs) are a kind of translational-repressor RNAs composed of more than 200 nucleotides and formerly considered as "transcriptional noise". Recently studies have show...
Although deep learning networks applied to digital images have shown impressive results for many pathology-related tasks, their black-box approach and limitation in terms of interpretability...
Patients with non-small cell lung cancer (NSCLC) harboring ROS proto-oncogene 1 (ROS1) gene rearrangements show dramatic response to the tyrosine kinase inhibitor (TKI) crizotinib. Current b...
This article has been reviewed so that we could detect how Cancer immunotherapy with immune checkpoint inhibitors (ICIs) has revolutionized the management of a wide variety of malignancies. ...
There is a growing interest in electronic nose-based diagnostic systems that are fast and portable. However, existing technologies are suitable only for operation in the laboratory, making t...
Residents in respiratory medicine are often confronted with breaking bad news to patients. In communication skill training, a recurring question is whether to use standardized or peer-played...
Monoclonal antibody (mAb) based therapies may provide a valuable new treatment modality for acute and chronic lung diseases, including asthma, respiratory infections, and lung cancer. Curren...
Although central nervous system (CNS) metastases frequently occur in patients with non-small cell lung cancer (NSCLC), historically these patients have been excluded from clinical trials. Ho...
This study aims to investigate the oncological outcomes of video-assisted thoracoscopic (VATS) left upper tri-segmentectomy (LTS) versus left upper lobectomy (LUL) for patients presenting wi...
Segmentectomy is gaining popularity as a parenchyma sparing alternative for anatomic lung resection. We sought to investigate temporal changes in patient selection, case volume and outcomes ...
Liquid biopsies based on extracellular vesicles (EVs) represent a promising tool for treatment monitoring of tumors, including non-small-cell lung cancers (NSCLC). In this study, we report o...
Extract from Kushen (Sophora flavescens Aiton) and Baituling (Heterosmilax japonica Kunth), Compound Kushen Injection has a long history for cancer treatment in China. As a common adjunctive...
In many high-income countries cancer mortality rates have declined, however, socioeconomic inequalities in cancer mortality have widened over time with those in the most deprived areas beari...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
